Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study.
Dirk TomsitzTheresa RufMarkus Vincent HepptRamon StaegerEgle RamelyteReinhard DummerMarlene GarzarolliFriedegund MeierEileen MeierHeike RichlyTanja GromkeJens Thomas SivekeCindy FranklinKai-Christian KlespeCornelia MauchTeresa KilianMarlene SeegräberBastian SchillingLars E FrenchCarola BerkingLucie HeinzerlingPublished in: Cancers (2023)
Data from this real-life cohort showed a median PFS/OS similar to published Phase 3 trial data. Treatment with ICI followed by tebentafusp may result in longer PFS/OS compared to the inverse treatment sequence.